Zonghai LI

Person

Shanghai, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Combination of cellular immunotherapy
- Patent number 12,178,786
- Issue date Dec 31, 2024
- CRAGE Medical Co., Limited
- Zonghai Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods of cellular immunotherapy
- Patent number 11,596,653
- Issue date Mar 7, 2023
- CRAGE medical Co., Limited
- Zonghai Li
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Binding unit targeting fibroblast activation protein α and applicat...
- Patent number 11,447,570
- Issue date Sep 20, 2022
- CRAGE MEDICAL CO., LIMITED
- Zonghai Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD19 humanized antibody and immune effector cell targeting cd 19
- Patent number 11,427,633
- Issue date Aug 30, 2022
- CRAGE medical Co., Limited
- Peng Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods of cellular immunotherapy
- Patent number 11,419,895
- Issue date Aug 23, 2022
- CRAGE Medical Co., Limited
- Zonghai Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric antigen receptor-modified immune effector cell carrying PD...
- Patent number 11,299,525
- Issue date Apr 12, 2022
- CRAGE Medical Co., Limited
- Zonghai Li
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibody for anti-claudin 18A2 and use thereof
- Patent number 11,111,295
- Issue date Sep 7, 2021
- CAFA THERAPEUTICS LIMITED
- Peng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric antigen receptors targeting GPC3 and uses thereof
- Patent number 10,731,127
- Issue date Aug 4, 2020
- CarsGEN Therapeutics Limited
- Zonghai Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acids encoding chimeric antigen receptor proteins which bin...
- Patent number 10,604,740
- Issue date Mar 31, 2020
- CarsGEN Therapeutics Limited
- Zonghai Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multi-functional antibody polypeptide for cryptic epitope of epider...
- Patent number 10,023,639
- Issue date Jul 17, 2018
- CARSGEN THERAPEUTICS CO., LTD.
- Zonghai Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-human proBDNF monoclonal antibody, and uses thereof in pains
- Patent number 9,969,799
- Issue date May 15, 2018
- Shanghai Yile Biotechnology Limited
- Huamao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human epidermal growth factor receptor variant lacking an exon
- Patent number 8,796,421
- Issue date Aug 5, 2014
- Shanghai Cancer Institute
- Zonghai Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Epidermal growth factor receptor variants and pharmaceutical compos...
- Patent number 8,703,917
- Issue date Apr 22, 2014
- Shanghai Cancer Institute
- Zonghai Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-EFGRv3 monoclonal antibody
- Patent number 8,506,963
- Issue date Aug 13, 2013
- Shanghai Cancer Institute
- Zonghai Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHOD AND COMPOSITION FOR TREATING TUMORS
- Publication number 20240285761
- Publication date Aug 29, 2024
- CARSGEN THERAPEUTICS CO., LTD.
- Zonghai LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS OF CELLULAR IMMUNOTHERAPY
- Publication number 20240269175
- Publication date Aug 15, 2024
- Zonghai LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD94 ENGINEERED CELL AND COMPOSITION THEREOF
- Publication number 20240226151
- Publication date Jul 11, 2024
- CRAGE MEDICAL CO., LIMITED
- Zonghai LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CELLULAR IMMUNOTHERAPY USE
- Publication number 20240181055
- Publication date Jun 6, 2024
- CRAGE MEDICAL CO., LIMITED
- Zonghai LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR TRANSDUCING CELLS WITH VIRAL VECTOR
- Publication number 20240182920
- Publication date Jun 6, 2024
- CARSGEN THERAPEUTICS CO., LTD.
- Huamao WANG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD94 ENGINEERED CELL AND COMPOSITION THEREOF
- Publication number 20240131065
- Publication date Apr 25, 2024
- CRAGE MEDICAL CO., LIMITED
- Zonghai LI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED CELLS AND METHOD FOR ENGINEERING CELLS
- Publication number 20230310600
- Publication date Oct 5, 2023
- CRAGE MEDICAL CO., LIMITED
- Zonghai LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTIFUNCTIONAL IMMUNE EFFECTOR CELL AND USE THEREOF
- Publication number 20230272341
- Publication date Aug 31, 2023
- CRAGE MEDICAL CO., LIMITED
- Zonghai LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUMOR COMBINED IMMUNOTHERAPY
- Publication number 20230158071
- Publication date May 25, 2023
- CRAGE MEDICAL CO., LIMITED
- Zonghai LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LOW-TEMPERATURE STORAGE OF BIOLOGICAL SAMPLES
- Publication number 20230148586
- Publication date May 18, 2023
- CRAGE MEDICAL CO., LIMITED
- Zonghai LI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMMUNE EFFECTOR CELL IN WHICH EXPRESSION IS REGULATED BY CYTOKINES
- Publication number 20230143947
- Publication date May 11, 2023
- CRAGE MEDICAL CO., LIMITED
- Zonghai LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CLAUDIN 18.2 ANTIBODY AND USE THEREOF
- Publication number 20230061005
- Publication date Mar 2, 2023
- CRAGE MEDICAL CO., LIMITED
- Zonghai LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CELL FOR RESISTING TRANSPLANT REACTION AND METHOD
- Publication number 20220356447
- Publication date Nov 10, 2022
- CRAGE MEDICAL CO., LIMITED
- Zonghai LI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMMUNE EFFECTOR CELL FOR CO-EXPRESSING CHEMOKINE RECEPTOR
- Publication number 20220325241
- Publication date Oct 13, 2022
- CRAGE MEDICAL CO., LIMITED
- Zonghai LI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODY FOR ANTI-CLAUDIN 18A2 AND USE THEREOF
- Publication number 20220185880
- Publication date Jun 16, 2022
- CAFA THERAPEUTICS LIMITED
- Peng WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CELLULAR IMMUNOTHERAPY COMBINATION
- Publication number 20220152101
- Publication date May 19, 2022
- CARSGEN THERAPEUTICS CO., LTD.
- Zonghai LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNE EFFECTOR CELL AND USE THEREOF
- Publication number 20220127570
- Publication date Apr 28, 2022
- CAFA THERAPEUTICS LIMITED
- Hua JIANG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TCR FUSION PROTEIN AND CELL EXPRESSING TCR FUSION PROTEIN
- Publication number 20220127372
- Publication date Apr 28, 2022
- CAFA THERAPEUTICS LIMITED
- Zonghai LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD AND COMPOSITION FOR TREATING TUMORS
- Publication number 20220110973
- Publication date Apr 14, 2022
- CAFA THERAPEUTICS LIMITED
- Zonghai LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHEMOKINE EXPRESSING CELL AND USE THEREOF
- Publication number 20220096544
- Publication date Mar 31, 2022
- CAFA THERAPEUTICS LIMITED
- Zonghai LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNE EFFECTOR CELL TARGETING GPC3 AND APPLICATION THEREOF
- Publication number 20220056408
- Publication date Feb 24, 2022
- SHANGHAI CANCER INSTITUTE
- Zonghai LI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPY OF CLDN18 ANTIBODY AND CHEMOTHERAPY DRUGS
- Publication number 20220033491
- Publication date Feb 3, 2022
- CAFA THERAPEUTICS LIMITED
- Zonghai LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR GENE EDITING OF CELL ON THE BASIS OF CRISPR/CAS SYSTEM
- Publication number 20220017926
- Publication date Jan 20, 2022
- CAFA THERAPEUTICS LIMITED
- Zonghai LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
T-CELL EXPRESSING CHIMERIC RECEPTOR
- Publication number 20220016166
- Publication date Jan 20, 2022
- CAFA THERAPEUTICS LIMITED
- Zonghai LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CLL1-TARGETING ANTIBODY AND APPLICATION THEREOF
- Publication number 20210324087
- Publication date Oct 21, 2021
- CAFA THERAPEUTICS LIMITED
- Zonghai LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR TREATING TUMOR USING IMMUNE EFFECTOR CELL
- Publication number 20210292427
- Publication date Sep 23, 2021
- CAFA THERAPEUTICS LIMITED
- Zonghai LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENETICALLY ENGINEERED CELL AND APPLICATION THEREOF
- Publication number 20210213061
- Publication date Jul 15, 2021
- CARSGEN THERAPEUTICS CO., LTD.
- Zonghai LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF CELLULAR IMMUNOTHERAPY
- Publication number 20210113614
- Publication date Apr 22, 2021
- CARSGEN THERAPEUTICS CO., LTD.
- Zonghai LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING UNIT TARGETING FIBROBLAST ACTIVATION PROTEIN alpha AND APPL...
- Publication number 20200347151
- Publication date Nov 5, 2020
- CARSGEN THERAPEUTICS CO., LTD.
- Zonghai LI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SYNNOTCH RECEPTOR-REGULATED EXPRESSION OF IL12
- Publication number 20200347410
- Publication date Nov 5, 2020
- CARSGEN THERAPEUTICS CO., LTD.
- Zonghai LI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Person

Patents Grantslast 30 patents

Combination of cellular immunotherapy

Compositions and methods of cellular immunotherapy

Binding unit targeting fibroblast activation protein α and applicat...

Anti-CD19 humanized antibody and immune effector cell targeting cd 19

Compositions and methods of cellular immunotherapy

Chimeric antigen receptor-modified immune effector cell carrying PD...

Antibody for anti-claudin 18A2 and use thereof

Chimeric antigen receptors targeting GPC3 and uses thereof

Nucleic acids encoding chimeric antigen receptor proteins which bin...

Multi-functional antibody polypeptide for cryptic epitope of epider...

Anti-human proBDNF monoclonal antibody, and uses thereof in pains

Human epidermal growth factor receptor variant lacking an exon

Epidermal growth factor receptor variants and pharmaceutical compos...

Anti-EFGRv3 monoclonal antibody

Patents Applicationslast 30 patents

METHOD AND COMPOSITION FOR TREATING TUMORS

COMPOSITIONS AND METHODS OF CELLULAR IMMUNOTHERAPY

CD94 ENGINEERED CELL AND COMPOSITION THEREOF

CELLULAR IMMUNOTHERAPY USE

METHOD FOR TRANSDUCING CELLS WITH VIRAL VECTOR

CD94 ENGINEERED CELL AND COMPOSITION THEREOF

ENGINEERED CELLS AND METHOD FOR ENGINEERING CELLS

MULTIFUNCTIONAL IMMUNE EFFECTOR CELL AND USE THEREOF

TUMOR COMBINED IMMUNOTHERAPY

LOW-TEMPERATURE STORAGE OF BIOLOGICAL SAMPLES

IMMUNE EFFECTOR CELL IN WHICH EXPRESSION IS REGULATED BY CYTOKINES

ANTI-CLAUDIN 18.2 ANTIBODY AND USE THEREOF

CELL FOR RESISTING TRANSPLANT REACTION AND METHOD

IMMUNE EFFECTOR CELL FOR CO-EXPRESSING CHEMOKINE RECEPTOR

ANTIBODY FOR ANTI-CLAUDIN 18A2 AND USE THEREOF

CELLULAR IMMUNOTHERAPY COMBINATION

IMMUNE EFFECTOR CELL AND USE THEREOF

TCR FUSION PROTEIN AND CELL EXPRESSING TCR FUSION PROTEIN

METHOD AND COMPOSITION FOR TREATING TUMORS

CHEMOKINE EXPRESSING CELL AND USE THEREOF

IMMUNE EFFECTOR CELL TARGETING GPC3 AND APPLICATION THEREOF

COMBINATION THERAPY OF CLDN18 ANTIBODY AND CHEMOTHERAPY DRUGS

METHOD FOR GENE EDITING OF CELL ON THE BASIS OF CRISPR/CAS SYSTEM

T-CELL EXPRESSING CHIMERIC RECEPTOR

CLL1-TARGETING ANTIBODY AND APPLICATION THEREOF

METHOD FOR TREATING TUMOR USING IMMUNE EFFECTOR CELL

GENETICALLY ENGINEERED CELL AND APPLICATION THEREOF

COMBINATION OF CELLULAR IMMUNOTHERAPY

BINDING UNIT TARGETING FIBROBLAST ACTIVATION PROTEIN alpha AND APPL...

SYNNOTCH RECEPTOR-REGULATED EXPRESSION OF IL12